Following the past two days of declines, the Dow Jones Industrial Average (DJINDICES: ^DJI ) was back in positive territory for a brief time this morning. And while impatient investors might have asked why the index hadn't regained more of its losses yet, the news that it was out of the red might have been enough for others. But the fickle market has now sent the index back into the red, as it sits down 50 points at 11:45 a.m. EDT. And while the day is not over yet, one particularly infrequent event may have the index down and out before the closing bell.
Summer Solstice and the witching hour�
So not only is today the longest day of the year for the Northern Hemisphere, but it is also a day of "quadruple witching," during which four types of investment contracts are set to expire -- stock index futures, stock index options, stock options, and single stock futures. This event only happens four times a year, and the expiration may inspire traders and investors to close out their positions. With the recent news from the Fed, Wall Street may be especially jittery, possibly leading to extreme volatility in the market later in the day.
Hot Heal Care Companies To Watch For 2015: Mylan Inc (MYL)
Mylan Inc. (Mylan), incorporated in 1970, is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. The Company operates a specialty business, which is focused on respiratory, allergy and psychiatric therapies. Through Mylan Laboratories Limited, an Indian subsidiary, it manufactures and supply active pharmaceutical ingredient (API) for its own products and pipeline, as well as for third parties. On December 23, 2011, Mylan completed the acquisition of rights to develop, manufacture and commercialize a generic equivalent to GlaxoSmithKline�� Advair Diskus and Seretide Diskus incorporating Pfizer Inc.��, (Pfizer) dry powder inhaler delivery platform (the Respiratory Delivery Platform). In February 2012, Valeant Pharmaceuticals International, Inc. announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to the Company.
As of December 31, 2011, Mylan marketed a global portfolio of approximately 1,100 different products covering a range of therapeutic categories. It offers a range of dosage forms and delivery systems, including oral solids, topicals, liquids and semi-solids. In addition, it focuses on transdermal patches, high potency formulations, injectables, controlled release and respiratory delivery products. Mylan operates in two segments: Generics and Specialty. Its revenues are derived from the sale of generic and branded generic pharmaceuticals, specialty pharmaceuticals and API. Its generic pharmaceutical business is conducted in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA), and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its API business is conducted through Mylan Laboratories Limited, which is included within the Asia Pacific region in its Generi! cs segment. Its specialty pharmaceutical business is conducted by Dey Pharma, L.P. (Dey).
Generics Segment
The Company sales in the United States are derived through its wholly owned subsidiary Mylan Pharmaceuticals Inc. (MPI), its primary United States pharmaceutical research, development, manufacturing, marketing and distribution subsidiary, as well as through Mylan Institutional (MI). MPI�� net revenues are derived from the sale of solid oral dosage and transdermal patch products. MI�� net revenues are derived from the sale of its unit dose and injectable product offerings. In the United States, it has product portfolios consisting of approximately 340 products, of which approximately 305 are in capsule or tablet form in an aggregate of approximately 740 dosage strengths. Included in these totals are approximately 40 extended release products in a total of approximately 105 dosage strengths. Also included in it�� the United States product portfolio are four transdermal patch products in a total of 18 dosage strengths, which are developed and manufactured by Mylan Technologies, Inc. (MTI), its wholly owned transdermal technology subsidiary, and marketed and distributed by MPI.
The Company�� North America revenues also include those generated by its wholly owned subsidiary Mylan Pharmaceuticals ULC (MPC), which markets generic pharmaceuticals in Canada. MPC offers a portfolio of approximately 115 products in an aggregate of approximately 250 dosage strengths. Its generic pharmaceutical sales in EMEA are generated by its wholly owned subsidiaries in Europe, through which it has operations in 21 countries.
In France, through the Company�� subsidiary Mylan S.A.S., it markets a retail portfolio of approximately 215 products in an aggregate of approximately 455 dosage strengths. In Italy, it markets through its subsidiary Mylan S.p.A. a portfolio of approximately 150 products in an aggregate of approximately 285 dosage strengths. In Italy, it h! as market! share, based on value and volume, in the company-branded generic retail prescription market. In Spain, it markets through its subsidiary Mylan Pharmaceuticals S.L. a portfolio of approximately 100 products in an aggregate of approximately 220 dosage strengths. In Germany, it markets through its subsidiary Mylan dura a portfolio of approximately 150 products in an aggregate of approximately 330 dosage strengths. In the United Kingdom, it offers a product portfolio of approximately 175 products in an aggregate of approximately 315 dosage strengths. It markets generic pharmaceuticals in Asia Pacific through subsidiaries in Australia, New Zealand, India, Japan and Taiwan.
In Australia, the Company offers a portfolio of approximately 170 products in an aggregate of approximately 440 dosage strengths. Mylan Seiyaku, its wholly owned Japanese subsidiary, offers a portfolio of more than 380 products in an aggregate of approximately 500 dosage strengths. At Mylan Laboratories Limited, its dosage business produces antiretroviral (ARV) products, which are sold outside of India, and other finished dosage form (FDF) products, which are sold to third parties by other Mylan operations globally. In addition, Mylan Laboratories Limited offers a line of FDF products in the ARV market and manufactures non-ARV FDF products that are marketed by Mylan.
Specialty Segment
The Company�� specialty pharmaceutical business is conducted through Dey. Dey�� portfolio consists of branded specialty injectable, nebulized and transdermal products for life-threatening conditions. Dey�� revenues are derived through the sale of the EpiPen Auto-Injector. The EpiPen Auto-Injector, which is used in the treatment of severe allergic reactions, is an epinephrine auto-injector that has been sold in the United States and internationally.
Advisors' Opinion:- [By Ben Levisohn]
The stock market has dropped today as global economic disappointed and investors abandon some of the market’s highest-flying stocks, including Netflix (NFLX), Alexion Pharmaceuticals (ALXN), Facebook (FB), Mylan (MYL) and Michael Kors (KORS).
- [By Sean Williams]
Veloci-Raptor time?
First up is Raptor Pharmaceuticals (NASDAQ: RPTP ) with Procysbi (previously known as RP-103), its oral delayed and extended-release medication to treat nephropathic cystinosis. In trials, Procysbi proved to be non-inferior to the only other FDA-approved treatment for nephropathic cystinosis, known as Cystagon from Mylan (NASDAQ: MYL ) . - [By James Brumley]
The law’s upside and downside for the pharma industry are something of a gray area, but broadly speaking, the Affordable Care Act tends to favor generic drug makers like Mylan (MYL) and Actavis (ACT), and presents something of a burden on brand-name pharma companies like Pfizer (PFE) and Merck (MRK).
- [By Laura Brodbeck]
Thursday
Earnings Expected From: Barrick Gold Corporation (NYSE: ABX), Newmont Mining Corporation (NYSE: NEM), Mastercard Incorporated (NYSE: MA), Mylan, Inc (NASDAQ: MYL), Time Warner Cable Inc. (NYSE: TWC) Economic Releases Expected: Chinese manufacturing PMI, South Korean trade balance, US Personal income, Italian PPI, eurozone unemployment rate, French consumer spending, Spanish current accountFriday
Best Industrial Disributor Companies To Watch For 2014: Woodside Petroleum Ltd (WPL)
Woodside Petroleum Ltd (Woodside) is an Australia-based oil and gas company. Woodside, along with its subsidiaries is engaged in hydrocarbon exploration, evaluation, development, production and marketing. As of December 31, 2011, the Company produced around 700,000 barrels of oil equivalent each day from a portfolio of facilities, which it operates on behalf of some of the major oil and gas companies. It operating facilities include six liquefied natural gas (LNG) trains, five offshore platforms and four oil floating production storage and offloading (FPSO) vessels. It is one of the non-government operators LNG plants. The Company operates six segments: North West Shelf Business Unit, Australia Oil Business Unit, Pluto Business Unit, Browse Business Unit, United States Business Unit and Other. In September 2012, it sold a minority portion of its equity in the proposed Browse LNG Development to Japan Australia LNG (MIMI Browse) Pty Ltd. Advisors' Opinion:- [By Adam Haigh]
Energy producers advanced as crude oil prices rallied after the ousting of Egypt�� president fanned concern unrest will disrupt Middle East oil supply. Cnooc gained 2.1 percent to HK$12.80 in Hong Kong. China Petroleum & Chemical Corp., the nation�� largest refiner, rose 2.5 percent to HK$5.25. Woodside Petroleum Ltd. (WPL), Australia�� No. 2 energy producer, added 3 percent to A$35.64.
Best Industrial Disributor Companies To Watch For 2014: Western Refining Logistics LP (WNRL)
Western Refining Logistics, LP, incorporated on July 17, 2013, owns, operates, develops, and acquires terminals, storage tanks, pipelines, and other logistics assets. As of December 31, 2012, the Company�� assets includes pipeline and gathering assets and terminalling, transportation, and storage assets in the Southwestern portion of the United States, which included approximately 300 miles of pipelines and approximately 7.9 million barrels of active storage capacity, as well as other assets. The Company's assets are integral to the operations of Western�� refineries located in El Paso, Texas, and near Gallup, New Mexico.
As of December 31, 2012, the Company owns and operates two refineries, in El Paso, Texas and Gallup, New Mexico, with a total crude oil throughput capacity of 153,000 barrels per day (bpd). The Company does not take ownership of the hydrocarbons or products (other than certain additives) that it handles or engages in the trading of any commodities.
Advisors' Opinion:- [By Robert Rapier]
Western Refining Logistics (NYSE: WNRL) debuted on Oct. 10. The partnership was formed by Western Refining (NYSE: WNR) to own, operate, develop and acquire terminals, storage tanks, pipelines, and other logistics assets. WNRL’s assets include 300 miles of crude oil pipelines, gathering systems, and 566,000 barrels of crude oil storage located primarily in the Permian Basin. Most of its revenue is expected to be derived from two 10-year, fee-based agreements with Western Refining.
- [By Aimee Duffy]
It;s been a very robust year for master limited partnership IPOs to say the least. On Thursday, Western Refining (NYSE: WNR ) successfully spun off its midstream logistics MLP, Western Refining Logistics (NYSE: WNRL ) . The partnership became the 14th MLP to make its debut this year.
Best Industrial Disributor Companies To Watch For 2014: Market Vectors Coal ETF (KOL)
Market Vectors-Coal ETF�� (the Fund) investment objective is to replicate as closely as possible, before fees and expenses, the price and yield performance of the Stowe Coal Index (the Coal Index). Van Eck Associates Corporation is the investment adviser to The Fund.
As of December 31, 2007, the Stowe Coal Index consists of the stocks of 60 publicly traded companies. These companies are engaged in the mining and/or transportation of coal, the manufacture of coal mining equipment and the production of clean coal.
Advisors' Opinion:- [By John Udovich]
We recently added small cap coal stock�Alpha Natural Resources, Inc (NYSE: ANR) to our SmallCap Network Elite Opportunity (SCN EO)�portfolio as a short-term position despite the fact it has underperformed the Market Vectors-Coal ETF (NYSEARCA: KOL) along with President Obama�� ��ar on coal.��And while you might be leery of betting on a coal stock with almost four years left for the current administration to wield power, but there is a good reason why investors in small cap coal stocks like Alpha Natural Resources could be rewarded.
- [By Peter Krauth]
The best way to gain exposure to the potential coal bull is through the Market Vectors-Coal ETF (KOL). This fund invests in companies that generate at least 50% of their revenues from coal production, mining, mining equipment, transportation, or storage.
- [By Jonathan Yates]
As a result, the exchange traded funds for gold, SPDR Gold Shares (NYSE: GLD) and its coal-related counterpart, Market Vectors Coal (NYSE: KOL), are both down by more than 20 percent for 2013. Demand from Asia, the largest consumer of coal and gold, is needed to raise the share prices of Market Vectors Coal and SPDR Gold Shares.
- [By Ben Levisohn]
The�Market Vectors Coal�ETF�(KOL) dropped 21% last year, but has gained 6.3% during the past six months. Peabody Energy�(BTU), meanwhile, fell 25% last year but has climbed 27% during the past six months, Alpha Natural Resources�(ANR) declined 27% but has gained 41% and Arch�Coal�(ACI) plunged 38% but gained 25% during the last six months. Consol Energy (CNX) rose 20% last year and gained 19% during the last six months.
Best Industrial Disributor Companies To Watch For 2014: Take-Two Interactive Software Inc.(TTWO)
Take-Two Interactive Software, Inc. publishes, develops, and distributes interactive entertainment software, hardware, and accessories worldwide. The company develops and publishes software titles for various gaming and entertainment hardware platforms, including PlayStation3 and PlayStation2 computer entertainment systems, PlayStation Portable system, Xbox 360 video game and entertainment system, and Wii and DS systems, as well as for the personal computer and games for Windows. It offers products through its wholly owned labels Rockstar Games and 2K, which publishes titles under 2K Games, 2K Sports, and 2K Play. The company, through its subsidiary, Jack of All Games, also distributes software, hardware, and accessories in North America. Its proprietary brand franchises include Grand Theft Auto; Sid Meier's Civilization; Max Payne; Midnight Club; Manhunt; Red Dead Revolver; Bully; BioShock; Sid Meier's Railroads!; Sid Meier's Pirates!; Carnival Games; and Top Spin, as wel l as licensed brands comprise the sports games Major League Baseball 2K; NBA 2K; and NHL 2K. The company sells its software titles to retail outlets through direct relationships with large retail customers and third party distributors. Its customers include mass merchandisers, specialty retailers, video stores, electronics stores, toy stores, national and regional drug stores, and supermarket and discount store chains. The company was founded in 1993 and is headquartered in New York, New York.
Advisors' Opinion:- [By Jake L'Ecuyer]
Take-Two Interactive Software (NASDAQ: TTWO) was down, falling 3.32 percent to $19.95 after the company issued a weak outlook. For the first quarter, the company expected an adjusted loss of $0.35 to $0.25 per share on revenue of $120 million to $125 million. However, analysts expected a loss of $0.12 per share on revenue of $209.6 million.
- [By Maria Armental var popups = dojo.query(".socialByline .popC"); popups.forEach]
Take-Two Interactive Software Inc.(TTWO) swung to a fourth-quarter loss on a drop of nearly 35% in revenue, but topped analyst expectations and pointed to steady sales of new videogame titles including “Grand Theft Auto.”� Shares fell 3.4% to $19.93 premarket.
Best Industrial Disributor Companies To Watch For 2014: ABS-CBN Corp (ABS)
ABS-CBN Corporation is primarily involved in television and radio broadcasting, as well as in the production of television and radio programming for domestic and international audiences and other related businesses. The Company operates through three business segments. Broadcasting segment is principally involved in the television and radio broadcasting activities, which generates revenue from sale of national and regional advertising time. Cable and satellite business primarily develops and produces programs for cable television, including delivery of television programming outside the Philippines through its direct-to-home (DTH) satellite service, cable television channels and blocked time on television stations. Other businesses include movie production, consumer products and services. The Company�� subsidiaries include ABS-CBN Publishing, Inc., Star Recording, Inc., Roadrunner Network, Inc., Star Songs, Inc., Sarimanok News Network, Inc. and ABS-CBN Interactive, Inc. Advisors' Opinion:- [By John Emerson]
During the housing bubble, lending standards were becoming relaxed and the practice of bundling subprime loans into collateralized debt obligations (CDOs) became a mainstream practice. These securities were backed by highly inflated credit ratings even though the quality of the underlying assets was highly questionable. By 2007, the worldwide demand for this type of asset-backed security (ABS) was beginning to wane and the mortgages which provided the collateral for the securities were starting to come into question.
No comments:
Post a Comment